South Korea makes new push for US trade pact
This article was originally published in Scrip
Executive Summary
South Korean president Lee Myung-bak has again called for the urgent ratification of a pending free trade agreement (FTA) with the US, which includes provisions to strengthen intellectual property protection for innovative drugs. In an address to the opening of the National Assembly (parliament), he also highlighted the need to improve the efficiency of the domestic health insurance system and increase medical support for low-income families, although no detailed plans were given. Mr Lee's cabinet recently approved a new bill pushing for the approval of the roughly year-old trade pact, which is still awaiting Congressional clearance in the US but has been dogged by disputes over automobiles and the safety of US beef exports to South Korea.
You may also be interested in...
Quick Listen: Scrip's Five Must-Know Things
In this week's podcast edition of Five Must-Know Things: the shifting sands of pharma R&D; big pharma oncology strategies; semaglutide’s promise in heart failure; AstraZeneca looks to multiple cancer modalities; and an interview with Astellas’s chief strategy officer.
Quick Listen: Scrip's Five Must-Know Things
In this week's podcast edition of Five Must-Know Things: Genmab buys into ADCs; Roivant set to take on AbbVie in uveitis; Ipsen signs firs ADC pact; South Korea looks to build biotech momentum; and the end of the road for Acorda.
Quick Listen: Scrip's Five Must-Know Things
In this week's podcast edition of Five Must-Know Things: Merck & Co progresses cardiovascular strategy; Novo purchase builds heart failure presence; CRL setbacks for Regeneron; ITF faces challenging Duchenne field; and AbbVie needs to freshen up.